The Johns Hopkins Center for Indigenous Health, previously the Johns Hopkins Center for American Indian Health, is an American academic institution based in Baltimore, Maryland. It is part of the Johns Hopkins Bloomberg School of Public Health.
COVID-19
The Johns Hopkins Center for American Indian Health participated as a clinical trial site for the Pfizer-BioNTech COVID-19 vaccine clinical trial, with Laura Hammitt serving as site investigator.[1][2]
External links
BioNTech SE, & Pfizer. (2023, February 28). Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals. ClinicalTrials.gov. https://web.archive.org/web/20230420203001/https://clinicaltrials.gov/ct2/show/NCT04368728 ↩︎
Supplementary Appendix (p. 2). (2021). medRxiv. https://web.archive.org/web/20230826041437/https://www.medrxiv.org/content/medrxiv/early/2021/07/28/2021.07.28.21261159/DC1/embed/media-1.pdf ↩︎
